Optimizing the Management of Postpartum Urinary Retention — PUR  

Urinary Retention Clinical Trial

Official title: Optimizing the Management of Postpartum Urinary Retention: Postpartum Urinary Retention (PUR) Study

Status Terminated

Clinical Trial Summary

A study aimed at characterizing the comparing duration of catheterization for treatment of postpartum urinary retention (PUR) and characterizing short and long-term pelvic floor symptoms in women who have PUR.

Clinical Trial Description

The purpose of the study is to compare clinical outcomes of women with bladder distension injuries due to postpartum urinary retention (PUR) who have varying duration of catheterization for initial treatment of postpartum urinary retention.

Hypotheses

1. Longer duration of therapeutic catheterization will be associated with resolution of postpartum voiding dysfunction in women who sustain severe bladder distension injuries due to postpartum urinary retention.

Definition of resolution of postpartum voiding dysfunction:

A. A post void residual volume of less than half of initial instilled volume on the first retrograde voiding trial, AND B. No need for re-treatment for urinary retention within 1 week

2. The incidence of postpartum urinary retention (PUR) will vary by route of delivery, with operative vaginal delivery having the highest incidence.

3. Risk factors for PUR will be related to intrapartum and delivery conditions ;

Related Conditions & MeSH terms

• Urinary Retention

• NCT number: NCT04187365
• Study type: Interventional
• Source: Northwestern University
• Status: Terminated
• Phase: N/A
• Start date: November 22, 2019
• Completion date: February 27, 2022